Paeds · haematology-oncology-and-transfusion
Wilms tumour and renal malignancies
Also known as Nephroblastoma · Childhood kidney tumour · Clear cell sarcoma of kidney · Malignant rhabdoid tumour of the kidney · Congenital mesoblastic nephroma · Paediatric renal cell carcinoma
Fellowship guide to Wilms tumour and the paediatric renal malignancies. Covers nephroblastoma as the commonest renal malignancy of childhood arising from the nephrogenic blastema with the WT1 and 11p15 genetic hits and the syndromic predisposition of WAGR, Beckwith-Wiedemann and Denys-Drash, the peak age of three to four years and the classic presentation of a painless abdominal mass with haematuria and hypertension, the clear cell sarcoma and the malignant rhabdoid tumour and the congenital mesoblastic nephroma of the infant, the first-line ultrasound with Doppler of the renal vein and the inferior vena cava, the computed tomography or magnetic resonance imaging and the chest imaging for staging, the Children's Oncology Group do-not-biopsy strategy of the upfront radical nephrectomy against the SIOP strategy of preoperative chemotherapy, the risk-adapted vincristine, dactinomycin and doxorubicin chemotherapy and the selective radiotherapy, and the late effects of cardiotoxicity and renal irradiation.
On this page
Study tools
Your progress
Saved on this device.
Practise this topic
Target exams
Red flags
- A painless abdominal mass in a young child, found by the parent at bath time, is a malignant renal tumour until imaging and specialist review prove otherwise
- A renal mass that is hard, irregular, fixed or associated with haematuria or hypertension is a Wilms tumour or another paediatric renal malignancy until staged and treated
- A needle or open biopsy of a radiologically typical Wilms tumour is avoided in the Children's Oncology Group approach because tumour spill upstages the disease to stage three and raises the recurrence risk
- A child with a renal tumour and an intravascular tumour thrombus extending into the inferior vena cava or the right atrium needs the thrombus defined before the surgery because it changes the operative plan
- An infant with a rapidly enlarging abdominal mass and the clear cell sarcoma or the malignant rhabdoid tumour needs the bone and the brain imaging because both tumours metastasise there
Life stages
Care settings
Clinical exam formats
Board mappings
- Recognises the school-age child with the painless abdominal mass as the classic Wilms tumour presentation, and names it the commonest renal malignancy of childhood
- Identifies the red flag of a hard, fixed or rapidly enlarging abdominal mass with the haematuria and hypertension that declare a renal tumour
- Explains why an abdominal mass in a child is a malignant renal or adrenal tumour until the imaging and the specialist review settle the question
- Explains the biology of the Wilms tumour from the nephrogenic rest and the WT1, 11p15 and WTX genetic hits, and the syndromic predisposition of WAGR, Beckwith-Wiedemann and Denys-Drash
- Contrasts the Children's Oncology Group strategy of the upfront radical nephrectomy without the biopsy against the SIOP strategy of the preoperative chemotherapy, and defends each
- Coordinates the pathway from the ultrasound and the computed tomography or magnetic resonance imaging through the surgical staging and the risk-adapted chemotherapy and radiotherapy to the late-effects surveillance
- A firm painless abdominal mass in a young child that does not cross the midline is a Wilms tumour until imaging proves otherwise, and the biopsy is avoided in the Children's Oncology Group approach because of the tumour spill and the upstaging
- The classic triad of the abdominal mass, the haematuria and the hypertension points to the renal tumour, and the first test is the ultrasound with the Doppler of the renal vein and the cava
- The favourable-histology Wilms is cured in around ninety percent, while the anaplastic Wilms, the clear cell sarcoma and the malignant rhabdoid tumour carry the worse prognosis
- Counsels the family on the high cure rate of the favourable-histology Wilms tumour, the surgery-first pathway, and the late effects of the doxorubicin cardiotoxicity and the renal irradiation
- Builds the multidisciplinary plan that runs the paediatric oncology, the surgery, the radiation oncology, the nephrology and the cardiology together, with the renal function and the cardiac surveillance built in
- Synthesises the long-case child treated for a Wilms tumour into a survivorship plan covering the renal function, the cardiotoxicity, the secondary malignancy and the pregnancy risk
- Level 1: Recognition of the painless abdominal mass as a possible renal malignancy and the urgent referral for the imaging and the specialist review
- Level 2: Application of the diagnostic pathway with the ultrasound and the cross-sectional imaging, the avoidance of the biopsy in the typical case, and the staging
- Level 3: Coordination of the risk-adapted surgery, chemotherapy and radiotherapy, and the long-term late-effects surveillance across the oncology, the nephrology and the cardiology
- Wilms tumour as the commonest renal malignancy of childhood, the peak age of three to four years, and the genetics of the WT1 and the Beckwith-Wiedemann 11p15 locus
- The clinical presentation of the painless abdominal mass with the haematuria and the hypertension, and the first-line ultrasound and the computed tomography or magnetic resonance imaging
- The favourable versus the anaplastic histology and the differential of the clear cell sarcoma and the malignant rhabdoid tumour of the kidney
- Structured abdominal examination of the child with the suspected renal mass for the size, the mobility, the crossing of the midline and the signs of the hypertension and the haematuria
- Communication of a new Wilms tumour diagnosis to the child and the family, including the high cure rate, the surgery-first pathway, and the chemotherapy and its late effects
- Recognition of the oncologic emergencies of the tumour rupture and the intravascular tumour thrombus extending into the cava
- Wilms tumour as the commonest renal malignancy of childhood and a leading paediatric solid tumour
- The clinical presentation by age, the abdominal mass, the haematuria and the hypertension, and the syndromic associations
- The principles of the multimodal therapy with the upfront nephrectomy, the vincristine and dactinomycin chemotherapy, and the selective radiotherapy, and the age-related and the histology-related prognosis
- Recognition of the red flag clinical features of the paediatric renal mass that mandate the urgent imaging and the referral to the specialist centre
- Application of the initial stabilisation of the child with the renal tumour including the blood pressure control and the avoidance of the biopsy in the typical case
- Coordination of the diagnostic and the multidisciplinary treatment pathway for the child with the Wilms or another renal tumour
- Canadian approach to the urgent evaluation and referral of the child with the suspected renal mass
- The staging and the risk-adapted therapy of the Wilms tumour under the Children's Oncology Group and the SIOP protocols
- The long-term late effects of the doxorubicin and the abdominal radiotherapy and the surveillance of the paediatric Wilms tumour survivor
Overview & Definition
A mother finds a lump in her three-year-old's belly at bath time, the child is otherwise well, and the question at the bedside is whether this is an enlarged spleen, a distended bladder, or a kidney tumour. Wilms tumour, the nephroblastoma, is the commonest renal malignancy of childhood, and the single thing that separates the child who is cured from the child who is harmed is how fast the clinician recognises the painless abdominal mass, reaches the ultrasound, and refers to the specialist centre without biopsying the mass on the way. The tumour is an embryonal neoplasm that arises from the persistent nephrogenic blastema, the immature kidney-forming tissue that should have disappeared before birth, and it grows silently inside the kidney until a parent or a doctor feels it. [1]
The paediatric renal malignancies are a family rather than a single disease, and the histology and the age change everything. Wilms tumour dominates, peaking at three to four years of age and accounting for the great majority of the childhood renal tumours, while the clear cell sarcoma of the kidney, the malignant rhabdoid tumour and the congenital mesoblastic nephroma occupy the corners and carry the different prognoses. The renal cell carcinoma of the adolescent sits at the other end of the age range. Holding these tumours together, with the Wilms at the centre, is what allows the fellow to answer the questions the boards ask about the renal mass in a child. [1][3]
The first task at the bedside is not to name the tumour but to judge whether the child is in danger from a tumour rupture, a hypertension crisis, or a tumour thrombus in the inferior vena cava. The second task is to image the kidney and the cava, and the third is to build the multidisciplinary plan that runs paediatric oncology, paediatric surgery, radiation oncology, nephrology and cardiology together. The reason the topic sits at the heart of the fellowship examination is that the candidate who can read the pattern, reach the scan, and navigate the surgery-first pathway while protecting the future kidney and heart is demonstrating exactly the reasoning the boards reward. [4]
References10ShowHide
- [1]Spreafico F, Fernandez CV, Brok J Wilms tumour Nat Rev Dis Primers, 2021.PMID 34650095
- [2]Treger TD, Chowdhury T, Pritchard-Jones K The genetic changes of Wilms tumour Nat Rev Nephrol, 2019.PMID 30705419
- [3]Perotti D, Williams RD, Wegert J Hallmark discoveries in the biology of Wilms tumour Nat Rev Urol, 2024.PMID 37848532
- [4]Dome JS, Mullen EA, Dix DB Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor J Natl Compr Canc Netw, 2021.PMID 34416705
- [5]Graf N, Tournade MF, de Kraker J The role of preoperative chemotherapy in the management of Wilms' tumor. The SIOP studies Urol Clin North Am, 2000.PMID 10985144
- [6]Kalish JM, Becktell KD, Bougeard G Update on Surveillance for Wilms Tumor and Hepatoblastoma in Beckwith-Wiedemann Syndrome and Other Predisposition Syndromes Clin Cancer Res, 2024.PMID 39320341
- [7]Vujanić GM, D'Hooghe E, Graf N, et al. Prognostic significance of histopathological response to preoperative chemotherapy in unilateral Wilms' tumor: an analysis of 899 patients treated on the SIOP WT 2001 protocol Int J Cancer, 2021.PMID 34109628
- [8]Gadd S, Huff V, Walz AL A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor Nat Genet, 2017.PMID 28825729
- [9]Benedetti DJ, Varela CR, Renfro LA Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: a report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS-5 Cancer, 2024.PMID 37933882
- [10]Ehrlich P, Chi YY, Chintagumpala MM Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): a report from the Children's Oncology Group Ann Surg, 2017.PMID 28795993